Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
03/21/2020 - 20:22
DIASORIN
DiaSorin S.p.A. Shareholders' Meeting date change
03/21/2020 - 20:20
DIASORIN
Variazione data Assemblea degli Azionisti DiaSorin S.p.A.
03/20/2020 - 07:26
DIASORIN
DIASORIN COVID-19 TEST HAS RECEIVED FDA EMERGENCY USE AUTHORIZATION
03/20/2020 - 07:25
DIASORIN
DIASORIN - APPROVAZIONE FDA EUA TEST COVID-19 NEGLI USA
03/13/2020 - 17:13
DIASORIN
DiaSorin received BARDA funding to develop a rapid COVID-19 test
03/13/2020 - 17:12
DIASORIN
DiaSorin riceve finanziamento dal Governo Americano per lo sviluppo del test per il Coronavirus
03/11/2020 - 13:39
DIASORIN
DiaSorin - Cash flow generation and net profit hit record highs in 2019
03/11/2020 - 13:38
DIASORIN
DiaSorin - Generazione di cassa ed utile netto record nel 2019
03/10/2020 - 08:16
DIASORIN
DiaSorin - Development of Coronavirus test
03/10/2020 - 08:15
DIASORIN
DiaSorin avvia sviluppo test per Coronavirus
03/02/2020 - 07:59
DIASORIN
DiaSorin signs an exclusive licensing agreement for molecular diagnostic POC technology
03/02/2020 - 07:57
DIASORIN
DiaSorin sigla un accordo di licenza esclusiva con TTP per lo sviluppo di una soluzione molecclare Point-Of-Care
02/07/2020 - 07:58
DIASORIN
DiaSorin S.p.A.-Communication on total amount of voting rights
02/07/2020 - 07:57
DIASORIN
DiaSorin S.p.A.-Comunicazione ammontare complessivo diritti di voto
01/15/2020 - 16:44
DIASORIN
Annual Calendar of Corporate Events 2020
01/15/2020 - 16:43
DIASORIN
Calendario Annuale Eventi Societari 2020
12/20/2019 - 15:52
DIASORIN
Comunicato Internal Dealing
12/20/2019 - 15:50
DIASORIN
Acquisizione tramite conferimento di azioni
12/20/2019 - 15:48
DIASORIN
Conferimento di azioni
12/18/2019 - 18:04
DIASORIN
Acquisizione tramite conferimento di azioni
12/18/2019 - 17:59
DIASORIN
Conferimento di azioni
12/16/2019 - 14:09
DIASORIN
DIASORIN RECEIVES FDA CLEARANCE FOR SIMPLEXA VZV SWAB DIRECT MOLECULAR ASSAY
12/16/2019 - 14:08
DIASORIN
DIASORIN LANCIA IL TEST MOLECOLARE SIMPLEXA VZV DIRECT NEL MERCATO STATUNITENSE
12/13/2019 - 16:38
DIASORIN
Comunicato Internal Dealing

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are